A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer Meeting Abstract

  

Authors:	Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
Abstract Title:	A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
Meeting Title:	45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	27
Issue:	15 Suppl.
Meeting Dates:	2009 May 29-Jun 2
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2009-05-20
Start Page:	286s
Language:	English
ACCESSION:	WOS:000276606600041
PROVIDER:	wos
DOI:	10.1200/jco.2009.27.15_suppl.5539
Notes:	Meeting Abstract: 5539 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/129667